A Radioluminescent Metal–Organic Framework for Monitoring 225 Ac in Vivo
Journal of the American Chemical Society · 12.07.2023 · 145 (27) · 14679-14685
DOI: 10.1021/jacs.3c02325 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 27.06.2023. Verfasst von Yugang Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovatio…. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Neoplasms. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.
Abstract (Originalsprache)
225Ac is considered as one of the most promising radioisotopes for alpha-therapy because its emitted high-energy α-particles can efficiently damage tumor cells. However, it also represents a significant threat to healthy tissues owing to extremely high radiotoxicity if targeted therapy fails. This calls for a pressing requirement of monitoring the biodistribution of 225Ac in vivo during the treatment of tumors. However, the lack of imageable photons or positrons from therapeutic doses of 225Ac makes this task currently quite challenging. We report here a nanoscale luminescent europium-organic framework (EuMOF) that allows for fast, simple, and efficient labeling of 225Ac in its crystal structure with sufficient 225Ac-retention stability based on similar coordination behaviors between Ac3+ and Eu3+. After labeling, the short distance between 225Ac and Eu3+ in the structure leads to exceedingly efficient energy transduction from225Ac-emitted α-particles to surrounding Eu3+ ions, which emits red luminescence through a scintillation process and produces sufficient photons for clearcut imaging. The in vivo intensity distribution of radioluminescence signal originating from the 225Ac-labeled EuMOF is consistent with the dose of 225Ac dispersed among the various organs determined by the radioanalytical measurement ex vivo, certifying the feasibility of in vivo directly monitoring 225Ac using optical imaging for the first time. In addition, 225Ac-labeled EuMOF displays notable efficiency in treating the tumor. These results provide a general design principle for fabricating 225Ac-labeled radiopharmaceuticals with imaging photons and propose a simple way to in vivo track radionuclides with no imaging photons, including but not limited to 225Ac.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X) and Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institution…
- Key Laboratory of Radiation Physics and Technology of the Ministry of Education Institute of Nuclear Science and Technology, Sichuan University, Chengdu 610064, China.
- Frontiers Science Center for Rare Isotopes, Lanzhou University, Lanzhou 730000, China.
ORCID-Profile: Feize Li, Longlong Tian, Yaxing Wang, Ning Liu, Shuao Wang
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Y., Li, F., Cui, Z., Li, K., Guan, J., Tian, L., Wang, Y., Liu, N., Wu, W., Chai, Z., & Wang, S. (2023). A Radioluminescent Metal–Organic Framework for Monitoring 225 Ac in Vivo. Journal of the American Chemical Society, 145(27), 14679-14685. https://doi.org/10.1021/jacs.3c02325
Vancouver
Zhang Y, Li F, Cui Z, Li K, Guan J, Tian L, et al. A Radioluminescent Metal–Organic Framework for Monitoring 225 Ac in Vivo. Journal of the American Chemical Society. 2023;145(27):14679-14685. doi:10.1021/jacs.3c02325
BibTeX
@article{Zhang2023,
author = {Zhang, Yugang and Li, Feize and Cui, Zhencun and Li, Kai and Guan, Jingwen and Tian, Longlong and Wang, Yaxing and Liu, Ning and Wu, Wangsuo and Chai, Zhifang and Wang, Shuao},
title = {A Radioluminescent Metal–Organic Framework for Monitoring 225 Ac in Vivo},
journal = {Journal of the American Chemical Society},
year = {2023},
volume = {145},
number = {27},
pages = {14679--14685},
doi = {10.1021/jacs.3c02325}
}
EUVIMED